You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The test is based on 13 genes that form a gene signature in the blood of children with Kawasaki disease, and it enables KD to be distinguished from other diseases.
HalioDx's Immunoscore test, which measures host immune response at the tumor site, will be used to select patients for the trial.
The partnership will provide new point-of-care lipid testing devices to remote sites in Latin America, the Caribbean, and Asia-Pacific.
Google Cloud said that the augmented reality microscope would enable access to artificial intelligence models that can help military doctors with cancer detection.
The serum-based proteomic test gauges a pre-treatment immune profile that has shown in retrospective studies to identify patients who are likely to respond well to anti-PD-1 therapy.
The trial will use Natera's Signatera test to determine patient enrollment eligibility based on the presence of ctDNA and to evaluate response based on ctDNA clearance.
The planned Lighthouse Lab follows a partnership the company announced in June to build a national COVID-19 testing lab in Cardiff.
AmoyDx aims to develop a companion diagnostic for Merck KGaA's non-small cell lung cancer treatment Tepmetko, which was recently approved in Japan.
OneOncology, a network comprising community oncology practices across the US, will bring its patient data to the research-focused partnership.
The kit, which received EUA from the FDA in May, will be used to test clinical samples from patients at D-HH member hospitals.